A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander (CHILD)
Primary Purpose
Autism Spectrum Disorder, Wandering Behavior
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Electronic Tracking Device
Sponsored by
About this trial
This is an interventional other trial for Autism Spectrum Disorder
Eligibility Criteria
Inclusion Criteria:
- At least 18 years of age
- Parent of a child between the ages of 4 and 17 who currently has autism spectrum disorder (ASD), was diagnosed with ASD by a professional, and has wandered at least once in the preceding 3 months
- Currently lives in the United States
- Currently lives with child with ASD
- Has been living with child with ASD for at least 6 months
- Has reliable internet access to allow for completion of online questionnaires
Exclusion Criteria:
Current or past use of any electronic tracking device to address wandering behavior in the child with ASD
Sites / Locations
- Cohen Children's Medical Center of New York
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Electronic Tracking Device
Arm Description
Participants will be given a wearable electronic tracking device (ETD) to use for their child with autism spectrum disorder (ASD) for 6 weeks.
Outcomes
Primary Outcome Measures
Rates of participant retention
Participant retention will be assessed to evaluate the feasibility of all study procedures.
Rates of questionnaire completion
Questionnaire completion rates will be calculated to assess the feasibility of the proposed evaluation schedule.
Adherence to the intervention
The mean daily duration of participant use of the device will be assessed to evaluate the acceptability of the intervention.
Secondary Outcome Measures
Changes from baseline in Caregiver Strain Questionnaire (CGSQ) scores
The Caregiver Strain Questionnaire is a validated, 21-item instrument that was developed to measure the strain experienced by parents of children with emotional and behavioral disorders. A modified version of this questionnaire will be administered in order to evaluate parental strain due to wandering-related concerns. The questionnaire measures three dimensions of caregiver strain, including objective strain (11 items), internalized subjective strain (6 items), and externalized subjective strain (4 items). Each subscale score is calculated by averaging responses (on a five-point scale) to all items in the subscale. A global score is obtained by summing all three subscale scores, with higher scores indicating a greater degree of caregiver strain.
Changes from baseline in GAD-7 scores
The Generalized Anxiety Disorder 7-Item (GAD-7) scale is a validated measure of the severity of anxiety symptoms. Possible scores range from 0 to 21, with higher scores indicating more severe levels of anxiety.
Changes from baseline in BFDS scores
The Brief Family Distress Scale (BFDS) is a single-item measure for evaluating the experience of distress or crisis in families of children with developmental disabilities. Possible scores range from 1 to 10, with higher scores representing a greater degree of family distress.
Changes from baseline in the frequency of wandering-related disruptions to the household.
A weekly study-specific questionnaire will evaluate the perceived impact of the child's wandering behavior on parent, child, and family activities.
Perceived impact of the intervention
Study-specific questionnaires will assess the perceived impact of the intervention on the child's wandering behavior and on the well-being of the parent and child.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03814902
Brief Title
A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander
Acronym
CHILD
Official Title
A Prospective Pilot Study to Characterize the Impact on Families of Electronic Tracking Device Use by Children With Autism Spectrum Disorders Who Wander
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
January 15, 2019 (Actual)
Primary Completion Date
November 11, 2019 (Actual)
Study Completion Date
November 11, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Northwell Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasibility of all study procedures and the acceptability of the intervention will be evaluated.
Detailed Description
Wandering, or elopement, is a life-threatening behavior that has been reported to occur in a third of all children with autism spectrum disorders (ASD). Wearable electronic tracking devices (ETDs) that are able to pinpoint a child's location have emerged as an appealing intervention for families concerned about wandering risk. However, the impact of ETD use on the families of children who wander has never been studied prospectively. In this pilot study, parents will be provided with a commercially-available ETD to use for their child with ASD for 6 weeks. Preliminary data will be obtained to evaluate the impact of ETD use on the strain experienced by families due to their child's wandering behavior. The feasibility of all study procedures will be assessed in preparation for a larger subsequent trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder, Wandering Behavior
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
31 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Electronic Tracking Device
Arm Type
Experimental
Arm Description
Participants will be given a wearable electronic tracking device (ETD) to use for their child with autism spectrum disorder (ASD) for 6 weeks.
Intervention Type
Device
Intervention Name(s)
Electronic Tracking Device
Intervention Description
This commercially-available electronic tracking device uses Global Positioning System (GPS) technology to display the wearer's location on a mobile phone, tablet, or computer. The device may be securely attached to clothing and is designed to be worn by children with developmental disabilities. Parents may use the associated application to view the child's location when the device is turned on and active.
Primary Outcome Measure Information:
Title
Rates of participant retention
Description
Participant retention will be assessed to evaluate the feasibility of all study procedures.
Time Frame
6 weeks
Title
Rates of questionnaire completion
Description
Questionnaire completion rates will be calculated to assess the feasibility of the proposed evaluation schedule.
Time Frame
6 weeks
Title
Adherence to the intervention
Description
The mean daily duration of participant use of the device will be assessed to evaluate the acceptability of the intervention.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Changes from baseline in Caregiver Strain Questionnaire (CGSQ) scores
Description
The Caregiver Strain Questionnaire is a validated, 21-item instrument that was developed to measure the strain experienced by parents of children with emotional and behavioral disorders. A modified version of this questionnaire will be administered in order to evaluate parental strain due to wandering-related concerns. The questionnaire measures three dimensions of caregiver strain, including objective strain (11 items), internalized subjective strain (6 items), and externalized subjective strain (4 items). Each subscale score is calculated by averaging responses (on a five-point scale) to all items in the subscale. A global score is obtained by summing all three subscale scores, with higher scores indicating a greater degree of caregiver strain.
Time Frame
Baseline and Week 6
Title
Changes from baseline in GAD-7 scores
Description
The Generalized Anxiety Disorder 7-Item (GAD-7) scale is a validated measure of the severity of anxiety symptoms. Possible scores range from 0 to 21, with higher scores indicating more severe levels of anxiety.
Time Frame
Baseline, Week 6
Title
Changes from baseline in BFDS scores
Description
The Brief Family Distress Scale (BFDS) is a single-item measure for evaluating the experience of distress or crisis in families of children with developmental disabilities. Possible scores range from 1 to 10, with higher scores representing a greater degree of family distress.
Time Frame
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
Title
Changes from baseline in the frequency of wandering-related disruptions to the household.
Description
A weekly study-specific questionnaire will evaluate the perceived impact of the child's wandering behavior on parent, child, and family activities.
Time Frame
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
Title
Perceived impact of the intervention
Description
Study-specific questionnaires will assess the perceived impact of the intervention on the child's wandering behavior and on the well-being of the parent and child.
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least 18 years of age
Parent of a child between the ages of 4 and 17 who currently has autism spectrum disorder (ASD), was diagnosed with ASD by a professional, and has wandered at least once in the preceding 3 months
Currently lives in the United States
Currently lives with child with ASD
Has been living with child with ASD for at least 6 months
Has reliable internet access to allow for completion of online questionnaires
Exclusion Criteria:
Current or past use of any electronic tracking device to address wandering behavior in the child with ASD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrew Adesman, MD
Organizational Affiliation
Northwell Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cohen Children's Medical Center of New York
City
New Hyde Park
State/Province
New York
ZIP/Postal Code
11042
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
26845701
Citation
Kiely B, Migdal TR, Vettam S, Adesman A. Prevalence and Correlates of Elopement in a Nationally Representative Sample of Children with Developmental Disabilities in the United States. PLoS One. 2016 Feb 4;11(2):e0148337. doi: 10.1371/journal.pone.0148337. eCollection 2016.
Results Reference
background
Learn more about this trial
A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander
We'll reach out to this number within 24 hrs